OXYGENTA PHARMACEUTICAL
Back to Cashflow Statement
|
OXYGENTA PHARMACEUTICAL Last 5 Year Cash Flow from Operating Activities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹-28 Cr | ₹2.83 Cr | ₹-13 Cr | ₹-1.63 Cr | ₹-1.68 Cr |
What is the latest Cash Flow from Operating Activities ratio of OXYGENTA PHARMACEUTICAL ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹-28 Cr |
| Mar2025 | ₹2.83 Cr |
| Mar2024 | ₹-13 Cr |
| Mar2023 | ₹-1.63 Cr |
| Mar2022 | ₹-1.68 Cr |
How is Cash Flow from Operating Activities of OXYGENTA PHARMACEUTICAL Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-28 Cr | Negative | |
| Mar2025 | ₹2.83 Cr | Positive | |
| Mar2024 | ₹-13 Cr | Negative | |
| Mar2023 | ₹-1.63 Cr | Negative | |
| Mar2022 | ₹-1.68 Cr | - | |
Compare Cash Flow from Operating Activities of peers of OXYGENTA PHARMACEUTICAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| OXYGENTA PHARMACEUTICAL | ₹172.4 Cr | -1% | -12.1% | -16.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,684.0 Cr | -1.4% | -6.5% | 5.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹241,311.0 Cr | -2% | -2.7% | 40.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,079.0 Cr | -1.8% | -7% | 29.6% | Stock Analytics | |
| CIPLA | ₹107,528.0 Cr | 0.1% | -3% | -15.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,667.0 Cr | 0.2% | 6% | -2.4% | Stock Analytics | |
OXYGENTA PHARMACEUTICAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| OXYGENTA PHARMACEUTICAL | -1% |
-12.1% |
-16.6% |
| SENSEX | 2.7% |
-0.7% |
-10.5% |
You may also like the below Video Courses